CLASS I Drug recall · Reported 8 Oct 2014 · FDA Enforcement Report

Black Ant, 2800 mg, four capsules recalled by Eugene Oregon

Eugene Oregon is recalling Black Ant, 2800 mg, four capsules per, Manufacturer Qinghai Baojiantang Pharmaceutical, distributed in 11 states. The recall was initiated on 5 May 2014 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codesAll lots

Quantity recalled136 boxes

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number: D-1613-2014
FDA event ID: 68218
Recalling firm: Eugene Oregon, Levittown, PA
Classification: Class I
Status: Terminated
Recall initiated: 5 May 2014
FDA classified: 29 Sep 2014
Reported: 8 Oct 2014
Type: Voluntary: Firm initiated
Customers notified by: Letter
Reason category: Labeling Errors

Timeline

5 May 2014	Recall initiated by company
29 Sep 2014	Classified by FDA	+147 days
8 Oct 2014	Published in enforcement report	+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Marketed Without an Approved NDA/ANDA: Eugene FDA laboratory analyses determined they contain undeclared sildenafil.

Product as listed by the FDA

Black Ant, 2800 mg, four capsules per box, Manufacturer Qinghai Baojiantang Pharmaceutical Co., Ltd.

Where it was distributed

To retailers in MD, TX, FL, PA, IL, NJ, IN, LA, WA, ME, SC

Florida Illinois Indiana Louisiana Maryland Maine New Jersey Pennsylvania South Carolina Texas Washington

Questions about this recall

Why was it recalled?

Marketed Without an Approved NDA/ANDA: Eugene FDA laboratory analyses determined they contain undeclared sildenafil.

Which lots are affected?

All lots

Where was it sold?

To retailers in MD, TX, FL, PA, IL, NJ, IN, LA, WA, ME, SC

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

2 other products · FDA event 68218

This product is part of a recall event; the main page for the event is African Black Ant, 2800 mg recalled by Eugene Oregon.

Reported	Class	Recall	Company	Reason	Where
8 Oct 2014	CLASS I	African Black Ant, 2800 mg recalled by Eugene Oregon	Eugene Oregon	Labeling Errors	11 states
8 Oct 2014	CLASS I	Mojo Risen, 650 mg recalled by Eugene Oregon	Eugene Oregon	Labeling Errors	11 states

More recalls from Eugene Oregon

All 3

Reported	Class	Recall	Company	Reason	Where
8 Oct 2014Drug	CLASS I	Mojo Risen, 650 mg recalled by Eugene Oregon	Eugene Oregon	Labeling Errors	11 states
8 Oct 2014Drug	CLASS I	African Black Ant, 2800 mg recalled by Eugene Oregon	Eugene Oregon	Labeling Errors	11 states

Other Black Ant recalls

All 4

Reported	Class	Recall	Company	Reason	Where
7 Feb 2018Drug	CLASS II	Black Ant capsules, 4600mg, labeling is in foreign language recalled	A&H Focal	Hidden Drug Ingredients	NJ, NY
24 Sep 2014Drug	CLASS I	Black Ant, 4600 mg, four capsules recalled by Nova Products	Nova Products	Labeling Errors	Nationwide
16 Apr 2014Drug	CLASS I	Black Ant, 4600 mg x Product recalled by American Lifestyle.Com	American Lifestyle.Com	Labeling Errors	NY